As of 2025-07-03, the Fair Value of Ocular Therapeutix Inc (OCUL) is -6.05 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 9.10 USD, the upside of Ocular Therapeutix Inc is -166.47%.
With the market price of 9.10 USD and our fair value calculation, Ocular Therapeutix Inc (OCUL) is not a good investment. Investing in OCUL stocks now will result in a potential loss of 166.47%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -155.64 | -6.55 | -71.04 | -80.74 | -193.51 | -101.49 |
| YoY growth | -80.20% | 95.79% | -984.58% | -13.65% | -139.68% | -224.46% |
| Market Cap (mil) | 1,449.63 |
| P/E | |
| Forward P/E |
| EPS | -1.21 |
| Avg earnings growth rate | -224.46% |
| TTM earnings | -192.71 |